235 related articles for article (PubMed ID: 35349243)
1. Implantable Cardiovascular Devices: Current and Emerging Technologies for Remote Heart Failure Monitoring.
Gill J
Cardiol Rev; 2023 May-Jun 01; 31(3):128-138. PubMed ID: 35349243
[TBL] [Abstract][Full Text] [Related]
2. Remote Monitoring of Heart Failure in Patients with Implantable Cardioverter-Defibrillators: Current Status and Future Needs.
Theuns DAMJ; Radhoe SP; Brugts JJ
Sensors (Basel); 2021 May; 21(11):. PubMed ID: 34071624
[TBL] [Abstract][Full Text] [Related]
3. Advances in cardiac resynchronization and implantable cardioverter/defibrillator therapy: Medtronic Cobalt and Crome.
Gierula J; Paton MF; Witte KK
Future Cardiol; 2021 Jul; 17(4):609-618. PubMed ID: 33635121
[TBL] [Abstract][Full Text] [Related]
4. Sex Differences in Long-Term Outcomes With Cardiac Resynchronization Therapy in Mild Heart Failure Patients With Left Bundle Branch Block.
Biton Y; Zareba W; Goldenberg I; Klein H; McNitt S; Polonsky B; Moss AJ; Kutyifa V;
J Am Heart Assoc; 2015 Jun; 4(7):. PubMed ID: 26124205
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of Pharmacologic and Cardiac Implantable Electronic Device Therapies in Patients With Heart Failure and Reduced Ejection Fraction: A Systematic Review and Network Meta-Analysis.
Tseng AS; Kunze KL; Lee JZ; Amin M; Neville MR; Almader-Douglas D; Killu AM; Madhavan M; Cha YM; Asirvatham SJ; Friedman PA; Gersh BJ; Mulpuru SK
Circ Arrhythm Electrophysiol; 2019 Jun; 12(6):e006951. PubMed ID: 31159582
[TBL] [Abstract][Full Text] [Related]
6. Disease management: remote monitoring in heart failure patients with implantable defibrillators, resynchronization devices, and haemodynamic monitors.
Abraham WT
Europace; 2013 Jun; 15 Suppl 1():i40-i46. PubMed ID: 23737229
[TBL] [Abstract][Full Text] [Related]
7. Emerging Implantable-Device Technology for Patients at the Intersection of Electrophysiology and Heart Failure Interdisciplinary Care.
Mastoris I; Spall HGCV; Sheldon SH; Pimentel RC; Steinkamp L; Shah Z; Al-Khatib SM; Singh JP; Sauer AJ
J Card Fail; 2022 Jun; 28(6):991-1015. PubMed ID: 34774748
[TBL] [Abstract][Full Text] [Related]
8. Implementation and reimbursement of remote monitoring for cardiac implantable electronic devices in Europe: a survey from the health economics committee of the European Heart Rhythm Association.
Mairesse GH; Braunschweig F; Klersy K; Cowie MR; Leyva F
Europace; 2015 May; 17(5):814-8. PubMed ID: 25713012
[TBL] [Abstract][Full Text] [Related]
9. Measuring Physical Activity With Implanted Cardiac Devices: A Systematic Review.
Rosman L; Lampert R; Sears SF; Burg MM
J Am Heart Assoc; 2018 May; 7(11):. PubMed ID: 29773575
[TBL] [Abstract][Full Text] [Related]
10. Device Management in Heart Failure.
Angel BG; Saltzman H; Kusmirek LS
Curr Cardiol Rep; 2017 Sep; 19(11):114. PubMed ID: 28948481
[TBL] [Abstract][Full Text] [Related]
11. Cardiac Implantable Electronic Device Therapy in Heart Failure.
Hussein AA; Wilkoff BL
Circ Res; 2019 May; 124(11):1584-1597. PubMed ID: 31120815
[TBL] [Abstract][Full Text] [Related]
12. Battery longevity in cardiac resynchronization therapy implantable cardioverter defibrillators.
Alam MB; Munir MB; Rattan R; Flanigan S; Adelstein E; Jain S; Saba S
Europace; 2014 Feb; 16(2):246-51. PubMed ID: 24099864
[TBL] [Abstract][Full Text] [Related]
13. Comparative Effectiveness of Cardiac Resynchronization Therapy Among Patients With Heart Failure and Atrial Fibrillation: Findings From the National Cardiovascular Data Registry's Implantable Cardioverter-Defibrillator Registry.
Khazanie P; Greiner MA; Al-Khatib SM; Piccini JP; Turakhia MP; Varosy PD; Masoudi FA; Curtis LH; Hernandez AF;
Circ Heart Fail; 2016 Jun; 9(6):. PubMed ID: 27296396
[TBL] [Abstract][Full Text] [Related]
14. Facility-Level Variation and Clinical Outcomes in Use of Cardiac Resynchronization Therapy With and Without an Implantable Cardioverter-Defibrillator.
Kramer DB; Normand ST; Volya R; Hatfield LA
Circ Cardiovasc Qual Outcomes; 2018 Dec; 11(12):e004763. PubMed ID: 30562069
[TBL] [Abstract][Full Text] [Related]
15. Survival in Women Versus Men Following Implantation of Pacemakers, Defibrillators, and Cardiac Resynchronization Therapy Devices in a Large, Nationwide Cohort.
Varma N; Mittal S; Prillinger JB; Snell J; Dalal N; Piccini JP
J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28490521
[TBL] [Abstract][Full Text] [Related]
16. Devices in heart failure; diagnosis, detection and disease modification.
Gierula J; Kearney MT; Witte KK
Br Med Bull; 2018 Mar; 125(1):91-102. PubMed ID: 29342243
[TBL] [Abstract][Full Text] [Related]
17. Device therapy in advanced heart failure: what to put in and what to turn off: remote telemonitoring and implantable hemodynamic devices for advanced heart failure monitoring in the ambulatory setting and the evolving role of cardiac resynchronization therapy.
Smith SA; Abraham WT
Congest Heart Fail; 2011; 17(5):220-6. PubMed ID: 21906246
[TBL] [Abstract][Full Text] [Related]
18. Reducing events in patients with chronic heart failure (REDUCEhf ) study design: continuous hemodynamic monitoring with an implantable defibrillator.
Adamson PB; Conti JB; Smith AL; Abraham WT; Aaron MF; Aranda JM; Baker J; Bourge RC; Warner-Stevenson L; Sparks B
Clin Cardiol; 2007 Nov; 30(11):567-75. PubMed ID: 18000962
[TBL] [Abstract][Full Text] [Related]
19. Implantable devices to monitor patients with heart failure.
Karamichalakis N; Parissis J; Bakosis G; Bistola V; Ikonomidis I; Sideris A; Filippatos G
Heart Fail Rev; 2018 Nov; 23(6):849-857. PubMed ID: 30284661
[TBL] [Abstract][Full Text] [Related]
20. Implantable cardiovascular sensors and computers: interventional heart failure strategies.
Smith SA; Abraham WT
Curr Cardiol Rep; 2012 Oct; 14(5):611-8. PubMed ID: 22814631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
